Fay Nugent
Clinical Project Manager
Research
I am the Clinical Project Manager on the blood-stage and transmission blocking malaria vaccine programmes headed by Prof Simon Draper. This programme of work includes testing of first-time-in-man vaccines against both Plasmodium falciparum and P. vivax malaria, incorporating controlled human malaria infection to test efficacy.
Recent publications
-
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
Journal article
Jin J. et al, (2018), npj Vaccines, 3
-
EFFICACY OF THE NOVEL PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE RH5.1/AS01B IN A PHASE I/IIA CLINICAL TRIAL
Conference paper
Minassian A. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 581 - 582
-
IN SILICO T CELL EPITOPE PREDICTION IDENTIFIES HIGH VALUE RH5 EPITOPES THAT CORRELATE WITH RESPONSE IN VACCINEES
Conference paper
Terry F. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 582 - 582
-
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Journal article
Payne RO. et al, (2017), JCI Insight, 2
-
Abstract Book
Conference paper
(2017), The American Journal of Tropical Medicine and Hygiene, 97, 1 - 674